Literature DB >> 11725171

Glucose tolerance and age-associated decline in renal function of hypertensive patients.

J Ribstein1, G Du Cailar, A Mimran.   

Abstract

BACKGROUND: Renal function is thought to decrease with age in the general population, but the determinants of this age-associated evolution are poorly understood. Hypertension and diabetes mellitus, two leading causes of chronic renal failure in the elderly, may accelerate this decline. PATIENTS AND METHODS: Urinary clearances of [99mTc]diethylene triaminopentaacetic acid (DTPA) (glomerular filtration rate) and [131I]hippuran (effective renal plasma flow) were assessed in 227 never-treated essential hypertensives aged 20-69 years. Based on the oral glucose tolerance test, the study population consisted of 4% patients with previously unknown diabetes mellitus, 24% with impaired glucose tolerance and 72% with normal glucose tolerance.
RESULTS: When the population of 218 non-diabetic subjects was considered, glomerular filtration rate was inversely correlated with age and arterial blood pressure, and positively correlated with effective renal plasma flow, filtration fraction and fasting plasma glucose. In multivariate analysis, age and blood pressure were independent determinants of renal plasma flow, whereas renal plasma flow, age and fasting plasma glucose were independent determinants of glomerular filtration rate. The slope of the regression line relating glomerular filtration rate to age was steeper in patients with impaired glucose tolerance than in those with normal glucose tolerance (-1.52 +/- 0.28 versus -0.65 +/- 0.12, P < 0.01).
CONCLUSIONS: These results suggest that impaired glucose tolerance, which is seldom searched for in patients with essential hypertension, may be an important determinant of the age-associated decline in renal function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725171     DOI: 10.1097/00004872-200112000-00020

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

Review 1.  The aging kidney: a review--part II.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.

Authors:  Xiaoxin X Wang; Yuhuan Luo; Dong Wang; Luciano Adorini; Mark Pruzanski; Evgenia Dobrinskikh; Moshe Levi
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

Review 3.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

4.  Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.

Authors:  Daniel F Gudbjartsson; Hilma Holm; Olafur S Indridason; Gudmar Thorleifsson; Vidar Edvardsson; Patrick Sulem; Femmie de Vegt; Frank C H d'Ancona; Martin den Heijer; Jack F M Wetzels; Leifur Franzson; Thorunn Rafnar; Kristleifur Kristjansson; Unnur S Bjornsdottir; Gudmundur I Eyjolfsson; Lambertus A Kiemeney; Augustine Kong; Runolfur Palsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS Genet       Date:  2010-07-29       Impact factor: 5.917

5.  Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study.

Authors:  Moniek C M de Goeij; Nora Voormolen; Nynke Halbesma; Dinanda J de Jager; Elisabeth W Boeschoten; Yvo W J Sijpkens; Friedo W Dekker; Diana C Grootendorst
Journal:  BMC Nephrol       Date:  2011-08-11       Impact factor: 2.388

Review 6.  Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspective.

Authors:  Francis Cc Chow; Siew-Pheng Chan; Chii-Min Hwu; Sompongse Suwanwalaikorn; Akira Yt Wu; Susan Yu Gan; Manuel B Zacarias
Journal:  J Diabetes Investig       Date:  2012-12-20       Impact factor: 4.232

7.  Therapeutic strategies for sleep apnea in hypertension and heart failure.

Authors:  Akiko Noda; Seiko Miyata; Yoshinari Yasuda
Journal:  Pulm Med       Date:  2013-02-19

8.  An evaluation of glucose tolerance in essential hypertension.

Authors:  Armagan Tugrul; Sibel Guldiken; Betul Ugur-Altun; Ender Arikan
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.